The novel B cell-targeting therapy ianalumab demonstrated improvement over placebo in key Sjögren’s disease parameters, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback